| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Homology Medicines, Inc. | Chief Financial and Business Officer and Treasurer | Employee Stock Option (Right to Buy) | 213K | $2.86M | $13.42 | Feb 23, 2023 | Direct |
| Homology Medicines, Inc. | Chief Financial and Business Officer and Treasurer | Restricted Stock Units | 36K | $41.4K | $1.15 | Feb 23, 2023 | Direct |
| Lyra Therapeutics, Inc. | Director | Stock Option | 30K | Jun 13, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| LYRA | Lyra Therapeutics, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
| LYRA | Lyra Therapeutics, Inc. | Jun 30, 2023 | 1 | $0 | 4 | Jul 5, 2023 | Director |
| FIXX | Homology Medicines, Inc. | Feb 23, 2023 | 2 | $0 | 4 | Feb 27, 2023 | Chief Financial and Business Officer and Treasurer |
| FIXX | Homology Medicines, Inc. | Jan 9, 2023 | 1 | -$5.19K | 4 | Jan 11, 2023 | Chief Financial and Business Officer and Treasurer |
| FIXX | Homology Medicines, Inc. | Jan 1, 2023 | 4 | $0 | 4 | Jan 4, 2023 | Chief Financial and Business Officer and Treasurer Exhibit 24 - Power of Attorney |
| LYRA | Lyra Therapeutics, Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 21, 2022 | Director |
| FIXX | Homology Medicines, Inc. | Feb 24, 2022 | 2 | $0 | 4 | Feb 28, 2022 | CFO & Treasurer |
| FIXX | Homology Medicines, Inc. | Jan 1, 2022 | 3 | -$8.25K | 4 | Jan 12, 2022 | CFO & Treasurer |
| LYRA | Lyra Therapeutics, Inc. | May 26, 2021 | 1 | $0 | 4 | May 28, 2021 | Director |